title: Re: MPDL3280A (Anti-PD-L1) Treatment Leads to Clinical Activity in Metastatic Bladder Cancer.
authors.forename: Sam S
authors.initials: SS
authors.lastname: Chang
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007167:Immunotherapy; D008297:Male; D001749:Urinary Bladder Neoplasms / Q000628:therapy*
chemical_list: D000911:Antibodies, Monoclonal